Jan. 12 at 5:08 PM
$CDNA
Preliminary Fourth Quarter 2025 Financial Results
Revenue of approximately
$108 million, an increase of 25% year-over-year
Testing services revenue of approximately
$78 million, an increase of 23% year-over-year
Testing services volume of approximately 53,000, an increase of 17% year-over-year
Average revenue per test of approximately
$1,470 including approximately
$5 million in prior period revenue
Patient & digital solutions revenue of approximately
$17 million, an increase of 47% year-over-year
Product revenue of approximately
$13 million, an increase of 17% year-over-year
Share repurchase of
$12 million during the quarter for 773,000 shares at an average price of
$15.79 per share
🙌🏼🙌🏼🙌🏼
